Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 343

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 343
---
 had obtained € 28.7 two 20.0 8.7 two one year five years 90 two five years one-year 1.56 0.95 two four years 877 379

(2) On July 3, 2017, the Company borrowed from the Bank “ Société Générale” in order to finance the construction of its future headquarters. This loan amounting to a maximum of € 15,200 14,826

The loan release period was limited to August 30, 2019. On August 30, 2019, the Company drew down the remaining portion of the € 15,200 13,900 12

F-44

and development, the Company has for the time being suspended the project to build its new head office on the land acquired in Luminy. In the meantime, the loan will be used to finance several structuring projects (improvement of the information system, development of a commercial platform, development of additional premises rented, etc.). As of December 31, 2024, the remaining capital of the loan amounted to € 8,894 15,200 4,200 5,000 6,000 4.2

This loan bears a fixed interest rate of 2.01

(3) On March 13, 2023, the Company signed an amendment to the lease for the "Le Virage" building, reducing the surface area of the leased premises. The effective date of the lease amendment is March 15, 2023. As a result, and in accordance with IFRS 16, the impact on the consolidated balance sheet at the effective date of the lease amendment is as follows: write-off of a right of use (asset) of € 0.5 0.7

The table below shows the schedule for the contractual flows (principal only) as of December 31, 2022, 2023 and 2024 respectively :

  In thousand euros                                     Year ended December 31,                                                       
  Current financial liabilities                                            2022                 2023                 2024             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  State guaranteed loan Société Générale                                      —                           4,884                4,969  
  State guaranteed loan BNP Paribas                                           —                           2,144                2,167  
  State guaranteed loans - accrued interest